← Leaderboards
Sally R. Sarawar
Torrey Pines Inst For Molecular Studies
$6,355,696
Attributed
$7,400,678
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2009–19$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,400,678 · 4
By mechanism
R01$5,310,713 · 2
R44$1,489,965 · 1
R41$600,000 · 1
Top collaborators
- Pamuk Bilsel4 shared
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseVaccinesT-LymphocyteMediatingVirusT Cell ResponseLungAntibodiesViralVaccinationInfluenzaSeasonal InfluenzaVaccine SafetyAttenuated Live Virus VaccineHospitalizationImmune ResponsePandemic InfluenzaBaseAgedCessation Of LifeInfluenzavirusB-LymphocytesImmunityInfluenza Virus Vaccine
Grant awards (11)
Development of a novel highly effective influenza vaccine$655,680
R44 · FY2019 · AI
Development of a novel highly effective influenza vaccine$834,285
R44 · FY2018 · AI
A Novel Live Non-replicating Universal Vaccine for Influenza$608,733
R01 · FY2018 · AI · contact PI
A Novel Live Non-replicating Universal Vaccine for Influenza$892,212
R01 · FY2017 · AI · contact PI
A Novel Live Non-replicating Universal Vaccine for Influenza$1,101,041
R01 · FY2016 · AI · contact PI
A Novel Live Non-replicating Universal Vaccine for Influenza$799,507
R01 · FY2015 · AI · contact PI
Development of a novel highly effective influenza vaccine$300,000
R41 · FY2015 · AI
A Novel Live Non-replicating Universal Vaccine for Influenza$1,009,220
R01 · FY2014 · AI · contact PI
Development of a novel highly effective influenza vaccine$300,000
R41 · FY2014 · AI
Immunological control of a persistent viral infection$450,000
R01 · FY2010 · AI · contact PI
Immunological control of a persistent viral infection$450,000
R01 · FY2009 · AI · contact PI